Background: Estrogens have been implicated in the development of breast cancer. Preliminary evidence suggests that consumption of soy products, which contain isoflavones (phytoestrogens), can reduce serum estrogen levels. Our purpose was to determine the effect of soy consumption on serum estrogen levels in premenopausal women by use of a dietary intervention approach. Methods: Premenopausal Japanese women were randomly assigned to receive either a soymilk-supplemented diet (n = 31) or a normal (control) diet (n = 29). The women in the soymilksupplemented group were asked to consume about 400 mL of soymilk (containing about 109 mg of isoflavones) daily during a study period that involved three consecutive menstrual cycles. Follicular-phase blood samples were to be obtained in the menstrual cycles preceding (cycle 1) and following (cycle 3) the 2-month dietary intervention. All statistical tests were two-sided. Results: At the end of the study period, estrone and estradiol levels were decreased by 23% and 27%, respectively, in the soymilk-supplemented group and were increased by 0.6% and 4%, respectively, in the control group. The changes for each hormone between the two groups were not statistically significantly different. In the soymilksupplemented group, menstrual cycle length was increased by nearly 2 days, and, in the control group, it was decreased by approximately 1 day, a difference that was not statistically significant. A subgroup analysis restricted to subjects who provided follicular-phase blood samples on the same day or 1 day apart in menstrual cycles 1 and 3 showed a reduction in serum estrone levels in the soymilk-supplemented group that was of borderline statistical
It has been proposed that intake of isoflavones, i.e., genistein and daidzein (also termed phytoestrogens), which are abundant in soy products, can reduce women's risk of breast cancer (1, 2) . These phytoestrogens normally compete with estradiol for binding to estrogen receptors (3, 4) and may therefore interfere with estrogeninduced cellular proliferation. Studies (5, 6) have shown that isoflavones also affect cells by inhibiting their response to growth factors and activation of tyrosine kinase. There are epidemiologic studies that support the hypothesis that soy consumption is associated with lowering of risk of breast cancer (7) (8) (9) (10) (11) (12) . Nomura et al. (7) found an inverse association between intake of miso soup and subsequent risk of breast cancer. In case-control studies, a significant inverse association between soy consumption and breast cancer risk was observed in Chinese women by Lee et al. (8) but not by Yuan et al. (9) . Inverse association between tofu intake and breast cancer risk was reported in Japanese (10) and Asian-American (11) women. A recent study by Ingram et al. (12) demonstrated a reduction of breast cancer risk among women that was associated with high intake of phytoestrogen (as measured by urinary excretion of isoflavones and lignans).
There is a general agreement that hormones, in particular estrogens, are involved in the development of breast cancer (13) . Our particular interest has been to study the possibility that soy consumption decreases the serum levels of female steroid hormones. This decrease, in turn, may ultimately help prevent the development of breast cancer. In our recent crosssectional study (14) , we found a negative association between serum estradiol concentration and intake of soy products among premenopausal Japanese women. On the basis of this observation, we have undertaken a dietary intervention trial to assess the influence of soy consumption on the hormonal status of premenopausal Japanese women.
MATERIALS AND METHODS

Subjects and Dietary and Serum Measurements
All female students and teachers (n ‫ס‬ 72) (who were premenopausal and not pregnant) at a course given at a nurses' training school in Gifu, Japan, were invited to participate in the present study. Sixty-five of 72 agreed to participate as of April 1997. Of these, three who reported a history of endocrine diseases (diabetes [n ‫ס‬ 2] and adrenal disease [n ‫ס‬ 1]) and two who were taking hormonal medication were excluded from the study. No one had cancer, chronic hepatitis, or cardiovascular disease. This study was approved by the local institutional review board, and all of the participants provided written informed consent. The remaining 60 women were randomly assigned to either the soymilk-supplemented group or the control group. Women in the soymilk-supplemented group were instructed to consume about 400 mL of soymilk daily that was supplied to them by the study during the dietary study period. Study subjects did not consume soymilk from any source other than what was provided to them. We could not obtain urine samples from the study participants that could have helped to assess their compliance. Soymilk used for this study was purchased from Kibun Food, Chemifa Tokyo, Japan. Isoflavone concentration of soymilk was determined by the Japan Food Research Laboratory, Tokyo, by use of a previously described high-performance liquid chromatographic technique (15) . One hundred grams of soymilk (equal to 98.0 mL) contains 0.7 mg of daidzein, 9.4 mg of daidzin, 0.7 mg of genistein, and 16 mg of genistin. The structures of these compounds as well as those of estrone and estradiol are shown in Fig. 1 . Women in the control group continued with their usual diet. Both groups were asked to continue their usual lifestyle.
We assumed that the relationship between serum estradiol and isoflavone intake in our previous crosssectional study was applicable for the prediction of changes in serum estradiol after 2 months of dietary intervention in the present study. We expected a 38% decrease in estradiol concentration by isoflavone intake available from 400 mL of soymilk. We determined that at least 28 subjects in each group were required to have a power of 80% to detect this difference in serum estradiol levels with type I error (␣) ‫ס‬ 0.05.
Each woman completed a self-administered questionnaire providing basic demographic information and menstrual and reproductive histories before the initiation of the dietary study period.
The first day of the menstrual bleeding was recorded for each woman (day 1), and the dietary study period started on day 11 of the first menstrual cycle (cycle 1). Women in the soymilk-supple-mented group were instructed to consume about 400 mL of soymilk daily until day 11 of cycle 3. A fasting blood sample was collected on the morning of day 11 of cycle 1 and on day 11 of cycle 3. Each woman completed a series of daily 24-hour diet records from day 2 through day 10 of cycle 1 (diet record 1) and day 2 through day 10 of cycle 3 (diet record 2). In addition, women in the soymilksupplemented group recorded their soymilk consumption throughout the dietary study period. The intake of all soy products (soymilk, tofu, miso, soybeans, etc.) and the intake of macronutients and micronutrients were estimated from the diet records using the Standard Tables of Food Composition in Japan, 4th revised edition (16) . We approximated isoflavone intake from soy products other than soymilk with the use of data from previous studies (17, 18) . Detailed information about estimation of isoflavone intake has been described elsewhere (14) .
Each woman was weighed before and after the dietary study period. After the dietary study period, the onset dates of the following two menstruations were reported by the subjects.
The blood samples were centrifuged at 1300g for 10 minutes at room temperature within 3 hours of sample collection, and the serum was separated. The samples were divided into 1-mL aliquots and stored at −80°C until assayed. Serum concentrations of estrone, estradiol, and sex hormone-binding globulin (SHBG) were determined by radioimmunoassay using kits purchased from Eiken Chemical Co. Ltd. (Tokyo), Diagnostic Products Cooperation, Japan (Chiba), and Pharmacia & Upjohn Co. Ltd. (Tokyo), respectively. The intra-assay coefficients of variation were 7.4% for estrone, 2.5% for estradiol, and 7.8% for SHBG.
Statistical Analysis
To evaluate the effects of soymilk consumption on hormone status, the concentrations of estrone, estradiol, and SHBG prior to and after the dietary study period were compared with the soymilksupplemented and control groups using the MannWhitney test. The Mann-Whitney and the Wilcoxon matched pairs signed rank tests were used to compare values of variables at baseline and changes in those variables over the study period. Values for serum hormone concentrations and nutrient intakes were log transformed for Wilcoxon matched pairs signed rank test. Analysis of variance was applied to compare the lengths of the four cycles in each group. All P values were calculated from two-tailed tests of statistical significance.
Some blood samples could not be collected on day 11 of cycle 1 or day 11 of cycle 3 in some participants because of school holidays. Actual sampling dates varied from day 9 through day 13 for cycle 1 and from day 7 through day 14 for cycle 3. Therefore, we performed a subgroup (n ‫ס‬ 44) analysis restricted to subjects who provided blood samples no more than 1 day apart from menstrual cycles 1 and 3.
RESULTS
Sixty women (31 in the soymilksupplemented group and 29 in the control group) began the study. An initial comparison of preintervention age, height, weight, and other lifestyle variables, such as smoking status, parity, and age at menarche, showed no statistically significant differences between the soymilk-supplemented group and the control group (Table 1) .
Prior to random assignment, the initial diet for each group was almost identical with respect to intake of macronutrients and micronutrients as well as soy products and isoflavone (Table 1) .
Both the soymilk-supplemented group and the control group significantly decreased their intake of energy and of most nutrients over the dietary study period. In the soymilk-supplemented group, a statistically significant decrease (shown as %) was observed for energy (8.0%), carbohydrate (11.6%), calcium (10.3%), cholesterol (22.0%), carotene (35.7%), vitamins B 2 (15.0%) and C (34.4%), salt (19.4%), and alcohol (43.8%). In the control group, a statistically significant decrease (shown as %) was observed for energy (10.8%), protein (11.1%), fat (12.4%), cholesterol (16.6%), carbohydrate (9.4%), calcium (8.2%), retinol (12.7%), and vitamins B 2 (16.1%) and C (15.6%). However, nutrient densities (calculated as nutrient intake divided by energy) did not change statistically significantly except for increases in protein (9.8%), crude fiber (11.0%), iron (42.6%), and vitamins B 1 (11.8%) and E (23.5%) and decreases in carbohydrate (3.6%), cholesterol (16.6%), vitamin C (31.0%), and salt (11.8%) in the soymilk-supplemented group (data not shown). In the control group, nutrient densities did not change significantly for any nutrient we tested.
The mean (standard deviation [SD]) daily soymilk consumption estimated from the diet records was 354.8 mL (70.1 mL) in the soymilk-supplemented group. Based on the basis of the records of daily soymilk consumption throughout the dietary study period, the mean (SD) soymilk consumption was 365.0 mL (46.1 mL). The mean isoflavone intake was about 4.5-fold higher at the end of the dietary study period compared with the intake before it. This change was statistically significant (P ‫ס‬ .0001). Intake of soy products other than soymilk and isoflavone from these products was decreased in terms of the nutrient densities (20.4% and 19.3%, respectively) at the end of the dietary study period in the soymilk-supplemented group, but these differences did not attain statistical significance.
There were no statistically significant changes in isoflavone intake divided by energy in the control group before and after the dietary study period.
The initial and final concentrations of serum hormones are shown for each group in Table 2 . The estrone concentration was too low to be measured (<10 pg/mL) in two women in the soymilksupplemented group during the dietary study period; for analysis purposes, we assigned them a serum estrone concentration of 10 pg/mL. The mean estrone concentration significantly decreased by 23% (P ‫ס‬ .02) in the soymilk-supplemented group and, in the control group, it increased by 0.6%. The mean estradiol concentrations decreased by 27% in the soymilk-supplemented group and increased by 4% in the control group. However, these changes between the two dietary groups was not statistically significant (P ‫ס‬ .20 for estrone and P ‫ס‬ .22 for estradiol). SHBG remained relatively stable in both groups.
The 3rd and 4th menstrual cycles were, on average, nearly 2 days longer than the 1st menstrual cycle in the soymilksupplemented group, whereas, in the control group, these two cycles were nearly 1 day shorter than the 1st menstrual cycle (Table 3) . However, these changes in cycle length were not statistically significant in both groups. There was no signifi- We restricted our statistical analysis to women who provided blood samples no more than 1 day apart in cycles 1 and 3 (21 women in the soymilk-supplemented group and 23 women in the control group). Among these women, the days of blood collection ranged from day 9 through day 12 in cycle 1 as well as in cycle 3. There were no significant differences in the hormone concentrations at baseline between the two groups. The mean (SD) of soymilk intake per day was 360.7 mL (68.4 mL) in the soymilksupplemented group. The mean (SD) of estimated isoflavone intake collectively from soymilk and other soy products was 29.5 mg (27.1 mg) and 121.2 mg (22.3 mg) at baseline and at the end of the di- etary study period, respectively, in the soymilk-supplemented group. The corresponding figures for isoflavone intake in the control group were 22.0 mg (12.7 mg) and 20.6 mg (14.0 mg), respectively. Changes in intake of nutrients as well as isoflavone in the selected subgroups were similar to those observed for the complete subgroups, i.e., in all subjects (data not shown). Serum estrone concentration was significantly decreased by 30.1% (P ‫ס‬ .005) in the soymilk-supplemented group when the comparison was between values before and after the dietary study period and increased by 3% in the control group, respectively, although the difference in the change between the two groups was of only borderline significance (P ‫ס‬ .07) ( Table 2 ). Estradiol concentrations decreased by 33.2% in the soymilksupplemented group and increased by 10% in the control group, respectively, but these changes in values were not significantly different when both groups were compared. The 4th menstrual cycle was 3.4 days longer than the 1st menstrual cycle in the soymilk-supplemented group and 2.6 days shorter in the control group (Table 3) . However, these changes did not attain statistical significance.
DISCUSSION
Our results support the hypothesis that soy consumption alters circulating ovarian steroid hormone concentrations in premenopausal women. To our knowledge, only three studies have previously evaluated the effect of soy diet on the estrogen status of premenopausal women (19) (20) (21) . However, all of these studies were small (fewer than 15 subjects) and did not include a control group. In our study, we randomly allocated subjects to an experimental or a control group. The sample size of our study was larger than that in the previous studies, although it was not large enough to obtain sufficient power. With this sample size, the power of finding a significant difference in estrone concentration between the two groups was only 53%.
We should remark that, unlike published dietary intervention studies employing soy foods, in our study, subjects in both the soymilk-supplemented group and the control group consumed soy products at baseline. We thus essentially investigated the effect of higher versus lower level of soy intake on hormone concentrations.
Lu et al. (20) found decreased estradiol concentrations in six healthy premenopausal women during soy feeding of three 12-oz portions per day of soymilk (about 200 mg of isoflavones per day) for 1 month. Cassidy et al. (19) observed that the midcycle peaks of luteinizing hormone and follicle-stimulating hormone †Women from whom blood samples were obtained on the same day or 1 day apart of the menstrual cycles 1 and 3. ‡Two-sided P values were calculated using the Wilcoxon matched-pairs sign rank test. §Two-sided P values were calculated for the differences in changes between the two groups by use of the Mann-Whitney test. . †From day 11 of the 1st menstrual cycle to day 10 of the 3rd menstrual cycle. ‡Women from whom blood samples were obtained on the same day or 1 day apart of the menstrual cycles 1 and 3.
§All P values are two-sided.
were suppressed, but estradiol was increased during dietary intervention with soy protein (60 g soy protein containing 45 mg conjugated isoflavones). They later reported no changes in estradiol, luteinizing hormone, and follicle-stimulating hormone during the diet with a half dose of conjugated isoflavones or the same dose of unconjugated isoflavones (22) . Petrakis et al. (21) reported an increase in estradiol during the 6 months of soy consumption (38 g of soy protein isolate containing 38 mg of genistein). In their study, blood measurements were not taken at the same time point in the menstrual cycle. Therefore, changes in estradiol concentration were estimated using computer-generated best-fit curves.
The findings regarding changes in serum estradiol levels in previous studies are somewhat contradictory, which may be due to variations in the quantity of isoflavones consumed. Petrakis et al. (21) postulated that the sporadically elevated estradiol concentration observed in their study during the soy diet may represent evidence of competition between binding of estradiol and isoflavones to the estrogen receptors. Although serum estradiol levels may be increased by relatively low isoflavone intake as observed in the studies by Cassidy et al. (19) and Petrakis et al. (21) , high intake of isoflavones, due to the estrogenicity, may cause a decrease in the serum levels of luteinizing hormone and follicle-stimulating hormone. This may lead to a decrease in serum estrogen concentrations. In the present study and the study reported by Lu et al. (20) , the experimental subjects received a relatively large amount of isoflavones (about 100 and 200 mg, respectively), and both studies observed about a 30% decrease in serum estradiol concentration in the follicular phase. It is possible that isoflavones alter estradiol concentration through alteration of estrogen metabolism. The in vitro findings have shown that genistein antagonizes transforming growth factor-␣-induced synthesis of estrogen in granulosa and theca cells (23) and inhibits the activity of 17␤-hydroxysteroid oxidoreductase type I, an enzyme that converts estrone to estradiol (24) . The interaction between isoflavones (or their metabolites) and intestinal steroid hormone metabolism may be related to estradiol reduction. A similar type of interaction is postulated for the relationship between fiber intake and estradiol (25) .
No data have been previously published on the effects of soy consumption on serum estrone levels. A trend toward decrease in serum estrone seen in the present study provides additional support for the hypothesis that isoflavones may have the ability to reduce the synthesis of estrogens.
There was a suggestion of an increase in menstrual cycle length after the soy diet, although this did not attain statistical significance. Prolongation of menstrual cycle length after dietary intervention has been reported by Cassidy et al. (19) and Lu et al. (20) .
The mean cycle length of the 1st menstrual cycle was 2.6 days longer than that of the 4th menstrual cycle in the control group in the selected subgroup analysis ( Table 3 ). The reason why the length of the menstrual cycle of control groups decreased over the study period is unclear. It is possible that some factors other than diet may have been affecting cycle length and, therefore, the observed difference in cycle length changes between the two groups may be overestimated.
Serum estrone and estradiol levels fluctuate during the menstrual cycle. Estrogen concentrations in the soymilk-supplemented group may appear to be lower than those in the control group because increases in cycle length most likely reflect the elongation of the follicular phase (26) . Data on hormone concentrations of study participants throughout the menstrual cycles were unavailable. Slight increases of estrone and estradiol levels in the control group may have been related to the decreased cycle length. However, despite changes in cycle length, estrone and estradiol concentrations were quite stable in the control group compared with the soymilk-supplemented group. Since the fluctuation in levels of serum estrogens is part of natural physiology, it is important to emphasize that effects of soy supplementation may not be visible when the study size is not large. A much larger study (by size and duration) and more frequent determinations of serum estrogen levels are required to offset the variations due to natural physiologic changes.
We did not completely control the diet by providing the subjects with all foods during the study period. The diet was assessed using self-reported diet records.
However, biased reporting by any one study group is unlikely, and the comparison of dietary changes between the two groups is considered valid. Both dietary groups showed a decrease in energy intake and a decrease in consumption of some macronutrients based on the diet records. It could be due to seasonal change or omission of some foods they had as they became tired of keeping records. These reasons are unlikely to be dependent on the dietary group. In terms of nutrient densities, the change was mainly the intake of nutrients rich in soymilk in the soymilk-supplemented group. Relatively less control of diet and lifestyle during the study period likely enhanced participation rates, strengthening the generalizability of these findings.
The present study suggests that high intake of soymilk may modify circulating estrogen concentrations and possibly alter menstrual cycle length, both of which may be potentially beneficial for lowering the risk of breast cancer. Much larger studies are required to confirm the ability of soy products to reduce serum estrogen levels.
